Compare XNCR & CHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XNCR | CHCO |
|---|---|---|
| Founded | 1997 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2013 | 1995 |
| Metric | XNCR | CHCO |
|---|---|---|
| Price | $24.77 | $141.39 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 5 |
| Target Price | $31.42 | ★ $140.40 |
| AVG Volume (30 Days) | ★ 1.0M | 79.3K |
| Earning Date | 11-04-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 2.50% |
| EPS Growth | ★ 65.36 | 13.18 |
| EPS | N/A | ★ 4.55 |
| Revenue | ★ $125,576,000.00 | N/A |
| Revenue This Year | $14.05 | $4.29 |
| Revenue Next Year | N/A | $3.11 |
| P/E Ratio | ★ N/A | $30.70 |
| Revenue Growth | ★ 13.65 | N/A |
| 52 Week Low | $10.38 | $113.21 |
| 52 Week High | $30.61 | $148.99 |
| Indicator | XNCR | CHCO |
|---|---|---|
| Relative Strength Index (RSI) | 51.52 | 34.05 |
| Support Level | $23.36 | $120.03 |
| Resistance Level | $30.61 | $147.26 |
| Average True Range (ATR) | 1.03 | 2.45 |
| MACD | -0.09 | -0.50 |
| Stochastic Oscillator | 55.23 | 1.32 |
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.